scholarly journals Evaluation of sexual performance in women treated for breast cancer

Mastology ◽  
2020 ◽  
Vol 30 (Suppl 1) ◽  
Author(s):  
Letícia Sposito ◽  
Caroline Nakano Vitorino ◽  
Gislaine Maria Fontanetti Bortolotti ◽  
Andre Hideo Motoki ◽  
Daniel de Araújo Brito Buttros
Keyword(s):  
Breast Cancer ◽  
Stage Iv ◽  
Cross Sectional Study ◽  
Histopathological Diagnosis ◽  
Sexual Performance ◽  
Cross Sectional ◽  
Oncological Treatment ◽  
Informed Consent Form ◽  
Final Score

Objective: To assess the sexual performance (SP) pattern in women treated for breast cancer (BC). Methods: Cross-sectional study with 33 women treated for BC. We included women aged between 35 and 66 years, with histopathological diagnosis of breast cancer, who already concluded the initial oncological treatment (surgery, chemotherapy and radiotherapy), in stage IV, assisted in the Unified Health System. They signed the informed consent form. Oncological data, such as staging, type of surgery, type of adjuvant treatment and follow-up time were collected through the analysis of medical records. The women were submitted to individual interview to assess SP, and the Female Sexual Quotient (FSQ) questionnaire was applied. The FSQ is formed by 10 objective questions that score from 0 to 5 points according to the answer: never, infrequently or rarely, sometimes, nearly 50% of the time, most of the time, always. The final score is defined by the sum of points multiplied by 2, and the SP is classified as: poor (0-20), unfavorable (22-40), fair (42-60), good (62-80), and excellent (82-100). Mean/standard deviation and percentage rates were used for statistical analysis. The study was approved by the Research Ethics Committee, Plataforma Brasil/CAAE: 02241618.1.0000.5381. Results: The mean age and oncological follow-up were 55±11 years and 4.5±2 years, respectively. The most prevalent oncological data were: 35% were in stage 2; 84% were submitted to conserving surgery; 95%, to radiotherapy; 65% underwent chemotherapy; and 80% were on endocrine therapy. Regarding sexual performance, 62% spontaneously think about sex; 35% are always interested in sex; and 54% are always stimulated by the “foreplay”. During the sexual relation, 32% always get lubricated; 45% become more stimulated when the partner is aroused; 45% always relax their vagina appropriately; 45% never feel pain; 52% always get involved without distraction; 51% always reach orgasm; and 42% always wish to repeat sexual relations in the following days. After calculating the final score, the conclusion was that 6% have poor sexual performance; 20%, unfavorable; 20%, fair; 38%, good; and 16%, excellent. Conclusion: Most women treated for breast cancer present with sexual performance classified between good and excellent, according to the Female Sexual Quotient.

scholarly journals Evaluation of sexual dysfunction in Brazilian women with breast cancer: partial results

Mastology ◽  
2020 ◽  
Vol 30 ◽  
Author(s):  
Letícia Barbosa Sposito ◽  
Caroline Nakano Vitorino ◽  
Vanildo Prado ◽  
Felipe Bedran ◽  
Jair Verginio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sexual Dysfunction ◽  
Clinical Stage ◽  
Stage Iv ◽  
Conservative Surgery ◽  
Cross Sectional Study ◽  
Sexual Performance ◽  
Cross Sectional ◽  
First Line Therapy ◽  
Student’S T

Objective: To assess the pattern of sexual performance in women treated for breast cancer. Methods: This is a cross-sectional study on women treated for breast cancer. Inclusion criteria: to have undergone the first-line therapy for cancer and the cancer not being classified as stage IV. Data on cancer were collected by the analysis of medical records. For the evaluation of sexual performance, women were submitted to individual interviews, with the application of the Quociente Sexual – Versão Feminina (QS F) questionnaire. Sexual performance was classified as: bad, unfavorable, regular, good, and excellent. The diagnosis of sexual dysfunction was established to women with score ≤ 60. For descriptive analyses, absolute (n) and relative (%) frequencies were performed, and for the comparison between the quantitative variables the Student’s t-test was used. Results: 31 women with a mean age of 55.2 years were included, 35% were classified as clinical stage II, 84% underwent conservative surgery, 65% underwent chemotherapy, and 80% used endocrinotherapy. Regarding sexual performance, 62% spontaneously think about sex, 35% are always interested in sex, and 51.7% have some degree of pain during intercourse. After calculating the score, it was concluded that 6.5% had bad sexual performance; 19.4%, unfavorable; 19.4%, regular; 41.9%, good; and 12.8%, excellent. The mean score was 58.7 points (standard deviation = 21.4, median of 64, minimum of 16, and maximum of 90 points), and 45.2% of women were diagnosed with sexual dysfunction. The provided treatments and the length of follow-up did not have a significant correlation with sexual performance. Conclusion: Most women treated for breast cancer had sexual performance classified as “good and excellent,” although a significant percentage had a diagnosis of sexual dysfunction.

scholarly journals Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors?

2020 ◽  
Vol 16 (28) ◽  
pp. 2191-2195
Author(s):  
Fatih Yildiz ◽  
Berna Oksuzoglu
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Survivors ◽  
Medical Oncology ◽  
Tertiary Care ◽  
Cross Sectional Study ◽  
Voice Call ◽  
Cross Sectional ◽  
New Era ◽  
Oncology Center

Background: Telemedicine is seen as a savior during the COVID-19 pandemic. Materials & methods: This study is a descriptive cross-sectional study conducted with cancer patients who were interviewed via telemedicine from a tertiary care comprehensive oncology center. Results: A total of 421 patients were included in the study and 118 of them (28.0%) were >65 years old. Communication was provided most frequently by voice call (n = 213; 50.5%). The majority of the patients contacted by telemedicine had breast cancer (n = 270; 64.1%). For 135 patients (32.1%) no further examination or intervention was required and the previously planned follow-up visit was postponed by the clinician. Conclusion: This study showed that telemedicine could open a new era for medical oncology specialists.

scholarly journals Concerns of young women with breast cancer and theirs partners from chemotherapy to follow-up: a cross-sectional study

2016 ◽  
Vol 27 ◽  
pp. vi513
Author(s):  
L. Vanlemmens ◽  
A. Congard ◽  
C. Duprez ◽  
A.-S. Baudry ◽  
A. Lesur ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Young Women ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional

scholarly journals Pattern of Presentation of Patients With Breast Cancer in Iraq in 2018: A Cross-Sectional Study

2019 ◽  
pp. 1-6 ◽  
Author(s):  
Mohammed Tareq Mutar ◽  
Mohammed Saleh Goyani ◽  
Ali Mohammed Had ◽  
Aqeel Shakir Mahmood
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma ◽  
Lobular Carcinoma ◽  
Stage Iv ◽  
Tumor Stage ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Tubular Carcinoma ◽  
Female Patients

PURPOSE This study aims to describe the pattern of presentation of Iraqi female patients with breast cancer by assessing the grades and stages of their cancers at the time of presentation, to identify patients’ main complaints, and to discover whether there is any difference in presentation between patients in Iraq and those in other countries. PATIENTS AND METHODS This is a retrospective cross-sectional study that was performed in the National Center of Cancer in 2018. The target population was female patients with breast cancer who came to the Center for treatment and follow-up. A sample of 171 patients was drawn from this population. Self-evaluation forms were used in interviews with the patients to collect personal and sociodemographic data; clinical and histologic characteristics of the patients’ tumors were obtained from their medical records. Ethical approval was obtained. RESULTS Forty-five percent of the patients were younger than age 50 years, and 25% were younger than age 45 years. In all, 42.9% of the patients were diagnosed with stage III and 25% with stage IV cancer, and metastasis was diagnosed in 24.1%. In our study population, 53.4% of the tumors were found in the right breast, and 3.9% of patients had bilateral breast tumors. The most common histopathologic type was invasive ductal carcinoma (81.4%) followed by invasive lobular carcinoma (6.9%) and tubular carcinoma (5.9%). The patients’ most common complaints were breast lump (71.3%) and pain (18.9%). No correlation was found between tumor stage and breast self-examination, family history, education, occupation, histopathology, or grade. CONCLUSION Most of the patients are diagnosed at a late stage when treatment is less effective.

scholarly journals PERFIL EPIDEMIOLÓGICO DAS PACIENTES COM CÂNCER DE MAMA SUBMETIDAS A QUIMIOTERAPIA NEOADJUVANTE EM UM HOSPITAL DE SÃO LUIS-MA

2018 ◽  
Vol 5 (2) ◽  
pp. 21-24
Author(s):  
FERNANDO HENRIQUE RIBEIRO DO COUTO CORREA
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Treatment ◽  
Epidemiological Data ◽  
Cross Sectional Study ◽  
Cáncer De Mama ◽  
Breast Cancer Patients ◽  
Cross Sectional ◽  
Epidemiological Profile ◽  
Surgical Treatments

RESUMO Introdução: Anualmente são diagnosticados aproximadamente um milhão de novos casos de câncer, existindo uma prevalência de 4,4 milhões de mulheres que padecem dessa enfermidade. A quimioterapia neoadjuvante, é definida como qualquer tratamento quimioterápico prescrito antes do tratamento cirúrgico, com base nos resultados obtidos, passou-se a indicar o tratamento neoadjuvante em pacientes com tumores operáveis, permitindo a utilização de tratamentos cirúrgicos menos invasivos e  mais eficientes. Metodologia: Estudo retrospectivo, de corte transversal  para avaliar o perfil clínico-epidemiológico de pacientes com câncer de mama sob acompanhamento do Serviço de Mastologia do Hospital do Câncer Aldenora Belo (HCAB) na cidade de São Luis-MA  com uma amostragem de 56 pacientes durante o período de janeiro de 2015 a dezembro de 2015. RESULTADOS: Os resultados referem-se a 56 pacientes com dados clínico-epidemiológicos. Conclusão:  Os resultados encontrados demonstram a evolução no tratamento do câncer de mama avançado, o que é uma realidade em nossa região, devido a falta de programas de acesso ao rastreamento, principalmente no interior do Estado, o que permitiria diagnósticos precoces e tratamentos mais eficazes e menos lesivos a paciente.   Palavras-chave: Oncologia. Mama. Neoplasias. ABSTRACT Introduction: Approximately one million new cases of cancer are diagnosed annually, with a prevalence of 4.4 million women suffering from this disease. Neoadjuvant chemotherapy is defined as any chemotherapy treatment prescribed before the surgical treatment, based on the results obtained, it was indicated the neoadjuvant treatment in patients with operable tumors, allowing the use of less invasive and more efficient surgical treatments. Methodology: Retrospective, cross-sectional study to evaluate the clinical-epidemiological profile of breast cancer patients under follow-up of the Mastology Service of the Aldenora Belo Cancer Hospital (HCAB) in the city of São Luis-MA with a sample of 56 patients during the period from January 2015 to December 2015. RESULTS: The results refer to 56 patients with clinical-epidemiological data. Conclusion: The results show the evolution in the treatment of advanced breast cancer, which is a reality in our region, due to the lack of access programs to the tracing, mainly in the interior of the State, which would allow early diagnosis and more effective treatments and less harmful to the patient. Keywords: Oncology. Mama. Neoplasms.

Patterns in detection of recurrence among patients treated for breast cancer.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e14020-e14020
Author(s):  
Lena Saltbæk ◽  
Trine Allerslev Horsbøll ◽  
Birgitte Vrou Offersen ◽  
Michael Andersson ◽  
Anne Sofie Friberg ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Outpatient Visit ◽  
Recurrent Breast Cancer ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Duration Of Symptoms ◽  
Cancer Group ◽  
Outpatient Visits ◽  
Breast Cancer Group

e14020 Background: Follow-up programs for breast cancer should according to ASCO and ESMO consist of regular visits including anamnestic screening for symptoms of recurrence and physical examination for ten years in addition to regular mammography. Recently, the Danish guideline for follow-up after early breast cancer was revised. Today most patients are offered open access to an outpatient clinic, but no scheduled visits following the first year after surgery. This strategy has been studied in regards to psychological and health related quality of life outcomes, but not in regards to detection of recurrence and survival. The aim of this study was to quantify the recurrences detected at scheduled outpatient visits in Denmark before the implementation of revised follow-up guidelines. Furthermore, we aimed to assess whether the duration of symptoms prior to recurrence detection differed depending on type of visit when recurrence was detected. Methods: We conducted a cross-sectional study among 310 patients with recurrent breast cancer. Through medical records, we retrieved information on type of visit when recurrence was detected, localization of recurrence, symptoms reported, and duration of symptoms. Tumor characteristics were obtained from the Danish Breast Cancer Group database. Results: Among the 310 breast cancer recurrences, more than half were distant (59%), 26% were loco-regional, and 15% loco-regional and distant. Among the 199 patients still in outpatient follow-up at time of recurrence, recurrence was detected at a scheduled outpatient visit (21%), at a patient-requested extra outpatient visit (15%), by the general practitioner or other specialist (47%), or on a scheduled mammography (11%). Among patients with recurrence detected at a scheduled outpatient visit, the majority (88%) reported symptoms related to the recurrence. Patients who waited for the scheduled outpatient visit despite symptoms had a markedly longer duration of symptoms (median 21 weeks) prior to detection of recurrence than patients who requested an extra visit (median 8 weeks). Conclusions: One-fifth of recurrences among patients attending outpatient follow-up were detected at scheduled outpatient visits. The majority was symptomatic, but the patients had not altered their scheduled appointment. Whether recurrences like these will be detected in follow-up without scheduled visits is unknown. Some recurrences may be detected earlier, if patients can be educated to react on relevant symptoms, but some recurrences may be detected with further delay. Thus, more research in this area is needed.

Hearing Outcome of Stapes Surgery in NIENT, Bangladesh

2020 ◽  
Vol 26 (1) ◽  
pp. 31-36
Author(s):  
Md Zakaria Sarkar ◽  
AHM Ferdows Nur ◽  
Utpal Kumar Dutta ◽  
Muhammad Rafiqul Islam ◽  
Debabrota Roy ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Cross Sectional Study ◽  
Surgical Trauma ◽  
Group 14 ◽  
Progressive Hearing Loss ◽  
Cross Sectional ◽  
Hearing Gain ◽  
Hearing Outcome

Objective: The aim of this study was to evaluate hearing outcome after stapedotomy in patients with Otosclerosis. Methods: This cross sectional study was carried out from July 2017 to January 2019 in National Institute of ENT, Unit V. About 22 patients with Otosclerosis were included in this study. Diagnosis of Otosclerosis was based on the history, medical status with Otoscopy, Tuning fork tests and Audiometric tests. We compiled data on the pre and post operative air-bone gap (ABG) at 0.5, 1, 2 KHZ. The ABG was Calculated using AC and BC thresholds on the same audiogram. Post operative hearing gain was then Calculated from the ABG before the operation minus the ABG of the last follow up examination Results: In this study most of the cases were age group 14-30 years (72.7%), female (54.5%). Most common symptoms was progressive hearing loss, tinnitus (77.8%).The average preoperative hearing loss in this study was (AC) was 48.31±7.68. The average post opt. hearing (AC) at follow up was 28.95±10.30 with an average hearing gain of 15.40±8.53 dB which was significant. The average pre-operative ABG was 28.99 dB ± 8.10. The average post opt. ABG was analyzed at 1 follow up showed ABG 13.18±8.09 dB which was found to be significant. Conclusion: Stapedotomy is an effective surgical procedure for the treatment of otosclerosis which leads to improvement in patient’s quality of life. A favorable hearing outcome can be obtained by the combination of experienced hands with minimal surgical trauma and appropriate surgical technique. Bangladesh J Otorhinolaryngol; April 2020; 26(1): 31-36

THE RELATION OF COPPING STRATEGY BY LOOKING SOCIAL SUPPORT WITH STRESS LEVEL OF BREAST CANCER PATIENT WHO GONE TROUGH CHEMOTHERAPY

2018 ◽  
Vol 1 (1) ◽  
pp. 51-54
Author(s):  
Sri Burhani Putri
Keyword(s):  
Breast Cancer ◽  
Social Support ◽  
Cancer Patient ◽  
Breast Cancer Patient ◽  
Cross Sectional Study ◽  
P Value ◽  
Spiritual Support ◽  
Cross Sectional ◽  
Breast Cancer Chemotherapy ◽  
Patient Stress

Breast cancer is one of the most common illness that killed woman. One of the therapy to cure breast cancer is chemotherapy. Chemotherapy has side effect either physical and psychology, that caused people who’s in chemo therapy, prone to stress. Stress effected by many factors, such as characteristic and chopping strategy that patient has been using. The aim of this research is to get a perspective about the relation of characteristic and chopping strategy with breast cancer patient stress, whose in chemo therapy. This research using cross sectional study and taking sample by using accidental sampling method. The data analyzed by using bavariat and multivariat with variable result shows that breast cancer patient stress who has chemo therapy realted to age characteristic (p value = 0.00) the time since they diagnosed with cancer (pvalue = 0.03), how long they have chemo therapy (pvalue = 0.00) and chopping strategyby looking social support (pvalue = 0.00) looking for spiritual (pvalue = 0.00) with dominan variable which related to stress is chopping strategy to looking spiritual support (coeffecients B = -1.139).   Key words : Breast cancer, chemotherapy, stress  

EFFICACY OF TREATMENT OF H.PYLORI EARDICATION WITH STANDARD TRIPLE THERAPY IN PEPTIC ULCER PATIENTS

2011 ◽  
pp. 122-129
Author(s):  
Quang Di Bui ◽  
Phuoc Lam Nguyen
Keyword(s):  
Peptic Ulcer ◽  
Adverse Effects ◽  
Triple Therapy ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Duodenal Ulcers ◽  
Ulcer Disease ◽  
Intention To Treat ◽  
Standard Triple Therapy

Objectives: The aim of study is to evaluate the efficacy, tolerability and adverse effects of a standard triple therapy including Rabeprazole, Clarithromycin and Amoxicilline at Sai gon Hoan My hospital in order to consider treatment H.pylori for patients who have not yet eradicated before or need to be undertaked by alternative regimens. Methods: By descriptive cross-sectional study, the authors have examined 116 patients sufferring from peptic ulcer received 10-day therapy including Rabe (20mg b.d) plus Clari(500mg b.d) plus Amoxi(1g b.d). Eradication is confirmed with endoscopy after 4 weeks from completing of treatment. Results and Discussion: 100% of patients were initially included and noboby was dropped out of the follow-up satges. The mean age was 49 in which 62% was male, 73(62,9%) presented duodenal ulcer, 28(24,1%) gastric ulcer and 15(13%) simultaneous gastric and duodenal ulcers. All patients took medications correctly. Per-protocol and intention to treat eradication rates were both 75%(95% CI=73,4-78,3). Additionally, 62(53,4%) patients had at least one risky factor for peptic ulcer disease, smoking being the most common one 44(37,9%).The adverse effects were reported overall in 67% of the patients, mainly including changed taste, very bitter, tired 49%, trouble sleeping 12% and diarrhea 5%. Conclusion: this ten-day standard triple therapy used in this study is ineffective with high adverse effects.The first line eradication with new regimens should be alternative.

Sign in / Sign up

Export Citation Format

Share Document